Activity

Filter

Cancel
Date Panel Item Activity
6 actions
BabyScreen+ newborn screening v0.1699 GCM2 Zornitza Stark Tag treatable tag was added to gene: GCM2.
Tag endocrine tag was added to gene: GCM2.
BabyScreen+ newborn screening v0.1119 GCM2 Zornitza Stark Marked gene: GCM2 as ready
BabyScreen+ newborn screening v0.1119 GCM2 Zornitza Stark Gene: gcm2 has been classified as Green List (High Evidence).
BabyScreen+ newborn screening v0.1119 GCM2 Zornitza Stark Classified gene: GCM2 as Green List (high evidence)
BabyScreen+ newborn screening v0.1119 GCM2 Zornitza Stark Gene: gcm2 has been classified as Green List (High Evidence).
BabyScreen+ newborn screening v0.1118 GCM2 Zornitza Stark gene: GCM2 was added
gene: GCM2 was added to gNBS. Sources: Expert Review
Mode of inheritance for gene: GCM2 was set to BOTH monoallelic and biallelic (but BIALLELIC mutations cause a more SEVERE disease form), autosomal or pseudoautosomal
Publications for gene: GCM2 were set to 27745835; 20190276; 34967908; 35038313
Phenotypes for gene: GCM2 were set to Hyperparathyroidism 4, OMIM #617343; Hypoparathyroidism, familial isolated 2, OMIM #618883
Review for gene: GCM2 was set to GREEN
Added comment: Well established association. GoF for AD hyperparathyroidism, and LoF for AR hypoparathyroidism.

Variable age of onset.

Treatment for hypoPTH: calcium carbonate, calcitriol. HyperPTH: surgery?

Non-genetic confirmatory tests: calcium, phosphate, parathyroid hormone
Sources: Expert Review